E Popa

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

Abby B. Siegel, E. Cohen, Allyson J. Ocean et al. · Journal of Clinical Oncology · 2008 · 510 citations · Full text

Medicine, Oncology, Pharmacology +17

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response

Daniele Biasci, Martin Smoragiewicz, Claire M. Connell et al. · Proceedings of the National Academy of Sciences · 2020 · 258 citations · Full text

Life Sciences, Immunology, Oncology +17

Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study

Shelley Potter, Elizabeth J. Conroy, Ramsey I Cutress et al. · The Lancet Oncology · 2019 · 202 citations · Full text

Medicine, Plastic Surgery, Surgery +16

Sex difference in diffuse malignant peritoneal mesothelioma

Tristan D. Yan, E Popa, Erwin A. Brun et al. · British journal of surgery · 2006 · 70 citations · Full text

Medicine, Oncology, Surgery +12